The role of long non-coding RNAs in cardiac development and disease

Abstract

Cells display a set of RNA molecules at one time point, reflecting thus the cellular transcriptional steady state, configuring therefore its transcriptome. It is basically composed of two different classes of RNA molecules; protein-coding RNAs (cRNAs) and protein non-coding RNAs (ncRNAs). Sequencing of the human genome and subsequently the ENCODE project identified that more than 80% of the genome is transcribed in some type of RNA. Importantly, only 3% of these transcripts correspond to protein-coding RNAs, pointing that ncRNAs are as important or even more as cRNAs. ncRNAs have pivotal roles in development, differentiation and disease. Non-coding RNAs can be classified into two distinct classes according to their length; i.e., small (<200 nt) and long (>200 nt) noncoding RNAs. The structure, biogenesis and functional roles of small non-coding RNA have been widely studied, particularly for microRNAs (miRNAs). In contrast to microRNAs, our current understanding of long non-coding RNAs (lncRNAs) is limited. In this manuscript, we provide state-of-the art review of the functional roles of long non-coding RNAs during cardiac development as well as an overview of the emerging role of these ncRNAs in distinct cardiac diseases.

Keywords

non coding RNAs - cardiac development - microRNAs - lcnRNAs

Publication History

Received: 30 October 2017

Accepted: 15 March 2018

Article published online:
10 May 2021

• References

• 1 Carninci P, Kasukawa T, Katayama S. et al. The transcriptional landscape of the mammalian genome. Science 2005; 309: 1559-1563
• 2 Harrow J, Frankish A, Gonzalez JM. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012; 22: 1760-1774
• 3 Esteller M. Non-coding RNAs in human disease. Nature Rev Gene 2011; 12: 861-874
• 4 Beermann J, Piccoli MT, Viereck J. et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 2016; 96: 1297-1325
• 5 Barwari T, Joshi A, Mayr M. MicroRNAs in Cardiovascular Disease. J Am College Cardiol 2016; 68: 2577-2584
• 6 Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18: 510-525
• 7 Derrien T, Johnson R, Bussotti G. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-1789
• 8 Fang S, Zhang L, Guo J. et al. NONCODEv5: a comprehensive annotation database for long non coding RNAs. Nucleic Acids Res 2017; 46: D308-D314
• 9 Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci 2016; 73: 2491-2509
• 10 Rosa A, Ballarino M. Long noncoding RNA regulation of pluripotency. Stem Cells Int 2015; 2016: 1-9
• 11 Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends in Cell Biol 2011; 21: 354-361
• 12 Dieci G, Fiorino G, Castelnuovo M. et al. The expanding RNA polymerase III transcriptome. Trends in Genet 2007; 23: 614-622
• 13 Rackham O, Shearwood AMJ, Mercer TR. et al. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA 2011; 17: 2085-2093
• 14 Pauli A, Norris ML, Valen E. et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science 2014; 343: 1248636
• 15 Pauli A, Valen E, Schier AF. Identifying (non-) coding RNAs and small peptides: Challenges and opportunities. BioEssays 2015; 37: 103-112
• 16 Nelson BR, Makarewich CA, Anderson DM. et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science 2016; 351: 271-275
• 17 Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol 2016; 17: 756-770
• 18 Gloss BS, Dinger ME. The specificity of long noncoding RNA expression. Biochim Biophysi Acta 2016; 1859: 16-22
• 19 BÄr C, Chatterjee S, Thum T. Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy. Circulation 2016; 134: 1484-1499
• 20 Chen LL. Linking Long Noncoding RNA Localization and Function. Trends in Biochem Sci 2016; 41: 761-772
• 21 Klattenhoff CA, Scheuermann JC, Surface LE. et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 2013; 152: 570-583
• 22 Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013; 154: 26-46
• 23 Ounzain S, Pedrazzini T. The promise of enhancer-associated long noncoding RNAs in cardiac regeneration. Trends Cardiovasc Med 2015; 25: 592-602
• 24 Ounzain S, Burdet F, Ibberson M. et al. Discovery and functional characterization of cardiovascular long noncoding RNAs. J Mol Cell Cardiol 2015; 89: 17-26
• 25 Memczak S, Jens M, Elefsinioti A. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495: 333-338
• 26 Wang K, Long B, Liu F. et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Euro Heart J 2016; 37: 2602-2611
• 27 Liu L, An X, Li Z. et al. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc Res 2016; 111: 56-65
• 28 Hasegawa Y, Brockdorff N, Kawano S. et al. The matrix protein hnRNP U is required for chromosomal localization of Xist RNA. Dev Cell 2010; 19: 469-476
• 29 Gupta RA, Shah N, Wang KC. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076
• 30 Grote P, Wittler L, Hendrix D. et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013; 24: 206-214
• 31 Tsai MC, Manor O, Wan Y. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693
• 32 Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res 2011; 71: 5365-5369
• 33 Mousavi K, Zare H, Dell'Orso S. et al. eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell 2013; 51: 606-617
• 34 Welsh IC, Kwak H, Chen FL. et al. Chromatin architecture of the Pitx2 locus requires CTCF-and Pitx2-dependent asymmetry that mirrors embryonic gut laterality. Cell Rep 2015; 13: 337-349
• 35 Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 2010; 38: 5797-5806
• 36 Han P, Li W, Lin CH. et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 2014; 514: 102-106
• 37 Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 2013; 425: 3723-3730
• 38 Tripathi V, Ellis JD, Shen Z. et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010; 39: 925-938
• 39 Yin QF, Yang L, Zhang Y. et al. Long Noncoding RNAs with snoRNA Ends. Mol Cell 2012; 48: 219-230
• 40 Kim YK, Furic L, Desgroseillers L. et al. Mammalian Staufen1 recruits Upf1 to specific mRNA 3″UTRs so as to elicit mRNA decay. Cell 2005; 120: 195-208
• 41 Kim YK, Furic L, Parisien M. et al. Staufen1 regulates diverse classes of mammalian transcripts. EMBO 2007; 26: 2670-2681
• 42 Faghihi MA, Modarresi F, Khalil AM. et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of Β-secretase expression. Nat Med 2008; 14: 723
• 43 Faghihi MA, Zhang M, Huang J. et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010; 11: R56
• 44 Yoon JH, Abdelmohsen K, Srikantan S. et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell 2012; 47: 648-655
• 45 Wang H, Iacoangeli A, Lin D. et al. Dendritic BC1 RNA in translational control mechanisms. J Cell Biol 2005; 171: 811-821
• 46 Carrieri C, Cimatti L, Biagioli M. et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012; 491: 454-457
• 47 Cesana M, Cacchiarelli D, Legnini I. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369
• 48 Keniry A, Oxley D, Monnier P. et al. The H19 lincRNA is a developmental reservoir of miR-675 which suppresses growth and Igf1r. Nat Cell Biol 2012; 14: 659
• 49 Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006; 127: 1101-1104
• 50 Wagner M, Siddiqui MAQ. Signal transduction in early heart development (I): cardiogenic induction and heart tube formation. Exp Biol Med 2007; 232: 852-865
• 51 Kelly RG, Buckingham ME, Moorman AF. Heart fields and cardiac morphogenesis. Cold Spring Harb Perspect Med 2014; 4: a015750
• 52 Christoffels VM, Habets PE, Franco D. et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000; 223: 266-278
• 53 Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012; 111: 1349-1362
• 54 Meganathan K, Sotiriadou I, Natarajan K. et al. Signaling molecules, transcription growth factors and other regulators revealed from in-vivo and in-vitro models for the regulation of cardiac development. Int J Cardiol 2015; 183: 117-128
• 55 Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008; 9: 219-230
• 56 Katz MG, Fargnoli AS, Kendle AP. et al. The role of microRNAs in cardiac development and regenerative capacity. Am J Physiol Heart Circ Physiol 2016; 310: H528-H541
• 57 Li H, Jiang L, Yu Z. et al. The Role of a Novel Long Noncoding RNA TUC40-in Cardiomyocyte Induction and Maturation in P19 Cells. Am J Med Sci 2017; 354: 608-616
• 58 Arnone B, Chen JY, Qin G. Characterization and analysis of long non-coding rna (lncRNA) in In Vitro-and Ex Vivo-derived cardiac progenitor cells. PloS One 2017; 12: e0180096
• 59 Liu J, Li Y, Lin B. et al. HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1. Dev Cell 2017; 42: 333-348
• 60 Ounzain S, Micheletti R, Beckmann T. et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur Heart J 2014; 36: 353-368
• 61 Ounzain S, Pedrazzini T. Long non-coding RNAs in heart failure: a promising future with much to learn. Annals Trans Med 2016; 4: 298
• 62 Ounzain S, Micheletti R, Arnan C. et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. J Mol Cell Cardiol 2015; 89: 98-112
• 63 Boucher JM, Peterson SM, Urs S. et al. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem 2011; 286: 28312-28321
• 64 Cordes KR, Sheehy NT, White MP. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710
• 65 Mathiyalagan P, Keating ST, Du XJ. et al. Chromatin modifications remodel cardiac gene expression. Cardiovasc Res 2014; 103: 7-16
• 66 Xue Z, Hennelly S, Doyle B. et al. A G-rich motif in the lncRNA braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage. Mol Cell 2016; 64: 37-50
• 67 Mahlapuu M, Ormestad M, Enerback S. et al. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development 2001; 128: 155-166
• 68 Grote P, Herrmann BG. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol 2013; 10: 1579-1585
• 69 Kurian L, Aguirre A, Sancho-Martinez I. et al. Identification of novel long non-coding RNAs underlying vertebrate cardiovascular development. Circulation 2015; 131: 1278-1290
• 70 Jiang W, Liu Y, Liu R. et al. The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression. Cell Rep 2015; 11: 137-148
• 71 Yamagashi H, Olson EN, Srivastava D. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest 2000; 105: 261-270
• 72 McFadden DG, CharitÉ J, Richardson JA. et al. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 2000; 127: 5331-5341
• 73 He A, Gu F, Hu Y. et al. Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat Commun 2014; 5: 4907
• 74 Anderson KM, Anderson DM, McAnally JR. et al. Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development. Nature 2016; 539: 433-436
• 75 Song G, Shen Y, Zhu J. et al. Integrated analysis of dysregulated lncRNA expression in fetal cardiac tissues with ventricular septal defect. PloS One 2013; 8: e77492
• 76 Song G, Shen Y, Ruan Z. et al. LncRNA-uc. 167 influences cell proliferation, apoptosis and differentiation of P19 cells by regulating Mef2c. Gene 2016; 590: 97-108
• 77 Gudbjartsson DF, Arnar DO, Helgadottir A. et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-357
• 78 Ellinor PT, Lunetta KL, Albert CM. et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675
• 79 Franco D, Christoffels VM, Campione M. Homeobox transcription factor Pitx2: The rise of an asymmetry gene in cardiogenesis and arrhythmogenesis. Trends Cardiovasc Med 2014; 24: 23-31
• 80 Gore-Panter SR, Hsu J, Barnard J. et al. PANCR, the PITX2 Adjacent noncoding RNA, is expressed in human left atria and regulates PITX2c expression. Circ Arrhythm Electrophysiol 2016; 9: e003197
• 81 Guo Y, Luo F, Liu Q. et al. Regulatory non-coding RNAs in acute myocardial infarction. J Cell Mol Med 2016; 21: 1013-1023
• 82 Vausort M, Wagner DR, Devaux Y. Long Noncoding RNAs in Patients With Acute Myocardial InfarctionNovelty and Significance. Circ Res 2014; 115: 668-677
• 83 Devaux Y, Creemers EE, Boon RA. et al. Circular RNAs in heart failure. Eur J Heart Fail 2017; 19: 701-709
• 84 Greco S, Zaccagnini G, Perfetti A. et al. Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med 2016; 14: 183
• 85 Schiano C, Costa V, Aprile M. et al. Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing. Cardiol J 2017; 24: 539-553
• 86 Micheletti R, Plaisance I, Abraham BJ. et al. The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Sci Transl Med 2017; 9: eaai9118
• 87 Li Z, Wang X, Wang W. et al. Altered long non-coding RNA expression profile in rabbit atria with atrial fibrillation: TCONS_00075467 modulates atrial electrical remodeling by sponging miR-328 to regulate CACNA1C. J Mol Cell Cardiol 2017; 108: 73-85
• 88 Ruan Z, Sun X, Sheng H. et al. Long non-coding RNA expression profile in atrial fibrillation. Int J Clin Exp Pathol 2015; 8: 8402
• 89 Viereck J, Kumarswamy R, Foinquinos A. et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med 2016; 8: 326ra22-326ra22
• 90 Wang Z, Zhang XJ, Ji YX. et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med 2016; 22: 1131-1139
• 91 Wang K, Liu F, Zhou LY. et al. The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 Novelty and Significance. Circ Res 2014; 114: 1377-1388
• 92 Zhu XH, Yuan YX, Rao SL. et al. Lncrna miat enhances cardiac hypertrophy partly through sponging mir-150. Eur Rev Med Pharmacol Sci 2016; 20: 3653
• 93 Piccoli MT, Gupta SK, Viereck J. et al. Inhibition of the Cardiac Fibroblast†Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction Novelty and Significance. Circ Res 2017; 121: 575-583
• 94 Tao H, Zhang JG, Qin RH. et al. LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology 2017; 386: 11-18
• 95 Qu X, Du Y, Shu Y. et al. MIAT is a pro-fibrotic long non-coding RNA governing cardiac fibrosis in post-infarct myocardium. Sci Rep 2017; 7: 42657
• 96 Huang ZW, Tian LH, Yang B. et al. Long noncoding RNA H19 acts as a competing endogenous RNA to mediate CTGF expression by sponging miR-455 in cardiac fibrosis. DNA Cell Biol 2017; 36: 759-766